» Articles » PMID: 31191541

Adipose Tissue-Resident Immune Cells in Obesity and Type 2 Diabetes

Overview
Journal Front Immunol
Date 2019 Jun 14
PMID 31191541
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammation is an important contributor to the pathogenesis of obesity-related type 2 diabetes (T2D). Adipose tissue-resident immune cells have been observed, and the potential contribution of these cells to metabolic dysfunction has been appreciated in recent years. This review focused on adipose tissue-resident immune cells that are dysregulated in the context of obesity and T2D. We comprehensively overviewed emerging knowledge regarding the phenotypic and functional properties of these cells and local factors that control their development. We discussed their function in controlling the immune response cascade and disease progression. We also characterized the metabolic profiles of these cells to explain the functional consequences in obese adipose tissues. Finally, we discussed the potential therapeutic targeting of adipose tissue-resident immune cells with the aim of addressing novel therapeutic approaches for the treatment of this disease.

Citing Articles

Immunometabolism of Tregs: mechanisms, adaptability, and therapeutic implications in diseases.

Lu Y, Wang Y, Ruan T, Wang Y, Ju L, Zhou M Front Immunol. 2025; 16:1536020.

PMID: 39917294 PMC: 11798928. DOI: 10.3389/fimmu.2025.1536020.


Investigating the potential role of T helper 17 cells among women experiencing overweight and obesity and their possible therapeutic targeting of the RORγt molecule.

Alhamawi R, Damfo S, Aloufi N, Almutawif Y, Suliman B Sci Rep. 2024; 14(1):29279.

PMID: 39592819 PMC: 11599566. DOI: 10.1038/s41598-024-81070-1.


Hypoxia-inducible factor-1α-deficient adipose-tissue macrophages produce the heat to mediate lipolysis of white adipose tissue through uncoupling protein-1.

Kang G, Kim Y, Oh H, Jo H, Bok S, Jeon Y Lab Anim Res. 2024; 40(1):37.

PMID: 39473019 PMC: 11523771. DOI: 10.1186/s42826-024-00224-4.


DNA sensors in metabolic and cardiovascular diseases: Molecular mechanisms and therapeutic prospects.

Kwak H, Lee E, Karki R Immunol Rev. 2024; 329(1):e13382.

PMID: 39158380 PMC: 11744256. DOI: 10.1111/imr.13382.


CD36 restricts lipid-associated macrophages accumulation in white adipose tissues during atherogenesis.

Chen V, Zhang J, Chang J, Beg M, Vick L, Wang D Front Cardiovasc Med. 2024; 11:1436865.

PMID: 39156133 PMC: 11327822. DOI: 10.3389/fcvm.2024.1436865.


References
1.
Weisberg S, McCann D, Desai M, Rosenbaum M, Leibel R, Ferrante Jr A . Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003; 112(12):1796-808. PMC: 296995. DOI: 10.1172/JCI19246. View

2.
Xu H, Barnes G, Yang Q, Tan G, Yang D, Chou C . Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003; 112(12):1821-30. PMC: 296998. DOI: 10.1172/JCI19451. View

3.
Caspar-Bauguil S, Cousin B, Galinier A, Segafredo C, Nibbelink M, Andre M . Adipose tissues as an ancestral immune organ: site-specific change in obesity. FEBS Lett. 2005; 579(17):3487-92. DOI: 10.1016/j.febslet.2005.05.031. View

4.
Chen A, Mumick S, Zhang C, Lamb J, Dai H, Weingarth D . Diet induction of monocyte chemoattractant protein-1 and its impact on obesity. Obes Res. 2005; 13(8):1311-20. DOI: 10.1038/oby.2005.159. View

5.
Gonzalez-Gay M, de Matias J, Gonzalez-Juanatey C, Garcia-Porrua C, Sanchez-Andrade A, Martin J . Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2006; 24(1):83-6. View